Pharmaceutical Executive
June 20, 2018
Columns
38
6
Azar and Gottlieb out front in revising rebates, restructuring Medicare, and promoting competition.
June 19, 2018
Features
38
6
Pharm Exec speaks with Joe Wiley, CEO of Amryt Pharma, who is steering a road-less-traveled path for a small pharma-building a sustainable, commercial infrastructure first, with the hopes of accelerating new rare disease drugs to the market.
June 18, 2018
Columns
38
6
Weighing the crossover effect of US’s new pricing blueprint.
June 18, 2018
Features
38
6
Exploring new character benchmarks for today’s pharma executives, and whether they have the transformational traits to lead through change.
June 11, 2018
From the Editor
38
6
My first gathering of Pharm Exec's Editorial Advisory Board was both an honor and a learning experience-about us, the industry, and maintaining our mission to the our readers.
June 11, 2018
Columns
38
6
Laboratory testing has become a critical access point for sales teams in the age of personalized medicine.
June 10, 2018
Columns
38
6
From AI to Alexa, experts in specialty pharma ponder the possibilities for high tech and the patient journey.
June 10, 2018
Columns
38
6
There is no magic bullet that will dramatically impact drug pricing to everybody’s liking. But a stepwise approach involving a series of reforms, including taking advantage of the next midterm elections, could point the path toward a solution.
June 01, 2018
Features
38
6
Pharm Exec’s 18th annual listing of the top biopharma players shows that most of the familiar placeholders are holding their ground as they weigh a changing business climate with new opportunities for growth in a potentially resurgent marketplace.
June 01, 2018
Issue PDF
38
6
Click the title above to open the Pharmaceutical Executive June 2018 issue in an interactive PDF format.